STABILISIERTES PACAP-PEPTID

European patent · EP3974027 · Deleted

Register entry

Publication number
EP3974027
Application number
EP20805414
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 14, 2020
Published
Mar 30, 2022
Granted
Oct 23, 2024
Deleted
Dec 23, 2025
Reason
Annual fee unpaid
IPC classes
C07K 14/575 (2006.01)
A61P 9/00 (2006.01)
A61P 25/00 (2006.01)
A61P 27/02 (2006.01)
A61P 29/00 (2006.01)
A61K 38/00 (2006.01)
Priority
JP 2019091696 14.05.2019
PCT application
PCT/JP2020/019344 14.05.2020
PCT publication
WO2020/230867 19.11.2020
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 23, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.12.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.12.2025

  2. Sep 3, 2025

    Change

    Published in Swissreg on 03.09.2025

  3. Oct 23, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 23.10.2024

Parties

Holder

Senju Pharmaceutical Co., Ltd.

3-1-9, Kawara-machi, Chuo-ku,, Osaka-shi, Osaka 541-0048, JP

Inventor

MACHIDA, Shinnosuke

Osaka-shi, Osaka 541-0048, JP

NAKAJIMA, Takeshi

Osaka-shi, Osaka 541-0048, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.